These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7104111)

  • 1. "Torsade de pointes" tachycardia. Re-entry or focal activity?
    D'Alnoncourt CN; Zierhut W; Blüderitz B
    Br Heart J; 1982 Sep; 48(3):213-6. PubMed ID: 7104111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
    Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible pathophysiology of torsade de pointes evaluated by a realistic heart computer model.
    Malik M; Camm AJ
    Cardiovasc Res; 1986 Jun; 20(6):436-43. PubMed ID: 3779739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early afterdepolarizations.
    Cranefield PF; Aronson RS
    Pacing Clin Electrophysiol; 1988 Jun; 11(6 Pt 1):670-8. PubMed ID: 2456546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphous ventricular tachycardia associated with normal and long Q-T intervals.
    Soffer J; Dreifus LS; Michelson EL
    Am J Cardiol; 1982 Jun; 49(8):2021-9. PubMed ID: 7081082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-wave alternans and Torsade de Pointes ventricular tachycardia in a patient with intracerebral hemorrhage].
    Tomcsányi J; Somlói M; Frész T; Beck K
    Orv Hetil; 2003 Oct; 144(42):2077-9. PubMed ID: 14658420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iatrogenic torsade de pointes induced by thioridazine].
    Paoloni P; Ciliberti D; Blasi N; Capone P
    Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial inducible torsade de pointes with normal QT interval.
    Strasberg B; Welch W; Palileo E; Swiryn S; Bauernfeind R; Rosen KM
    Eur Heart J; 1983 Jun; 4(6):383-90. PubMed ID: 6617684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism of torsades de pointes in a canine model.
    Bardy GH; Ungerleider RM; Smith WM; Ideker RE
    Circulation; 1983 Jan; 67(1):52-9. PubMed ID: 6847804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?
    Surawicz B
    J Am Coll Cardiol; 1989 Jul; 14(1):172-84. PubMed ID: 2661626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinidine-induced long QTU interval and torsade de pointes: role of bradycardia-dependent early afterdepolarizations.
    el-Sherif N; Bekheit SS; Henkin R
    J Am Coll Cardiol; 1989 Jul; 14(1):252-7. PubMed ID: 2738268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Torsade de pointes ventricular tachycardia].
    Mikhaĭlov P
    Vutr Boles; 1984; 23(5):72-7. PubMed ID: 6084362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmic storm: Short-coupled variant torsade de pointes.
    Godinho AR; Frutuoso C; Vasconcelos M; Dias P; Garcia R; Pinho T; Araújo V; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):307.e1-5. PubMed ID: 27132471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of magnesium on sustained ventricular tachycardia].
    Manz M; Jung W; Lüderitz B
    Herz; 1997 Jun; 22 Suppl 1():51-5. PubMed ID: 9333592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes complicating atrioventricular block: report of two cases.
    Maor N; Weiss D; Lorber A
    Int J Cardiol; 1987 Feb; 14(2):235-8. PubMed ID: 3818142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.